Diabetes Drugs Flashcards
Lispro (Humalog)
Onset: 10-15 min
Peak: 15-120 min
Duration: <5 hr
Glulisine (Apidra)
Rapid acting
Onset: 10-15 min
Peak: 15-120 min
Duration: <5 hr
Aspart (Novolog)
Rapid acting
Onset: 10-15 min
Peak: 15-120 min
Duration: <5 hr
Regular (R)
Rapid acting
Onset:30-60 min
Peak: 2-3 hr
Duration: 6-8 hr
NPH (N)
Intermediate acting
Onset: 2-4 hr
Peak: 6-10 hr
Duration: 10-16 hr
Glargine (Lantus)
long acting
onset 2-4 hours
no peak action
effective duration 20-24 hours
Determin (Levimir)
long acting
onset: 1 hours
no peak action
effective duration 20-24 hours
70%/30% Aspart protamine/aspart
Mixed intermediate/short acting
Onset: 30 min
Peak: 2-12 hr
Duration: 10-16 hr
50%/50% NPL/Lispro
Mixed intermediate/short acting
Onset: 30 min
Peak: 3-5 hr
Duration: 10-16 hr
75%/25% NPL/Lispro
Mixed intermediate/short acting
Onset: 15 min
Peak: 30-90 min
Duration: 10-16 hr
*Active profiles of insulin analogues
insulin lispro aspart, glulisine regular NPH Detemir Glargine
Insulin effects on glucose levels
Insulin lispro, aspart
Regular
NPH or lente
Ultralente or glargine
How Insulin pump works
Insulin in reservoir
Travels to cannula inserted in body
needle held by infusion set, adhesive patch
Difficulties of Insulin Pump
Physical activity
Insulin or battery could run out
kink in tube
Inhaled Insulin (exubera)
rapid acting dry powder
need larger dose
9% of insulin lingered in lungs long after 12 hr
accumulation problems and increase in lung cancer (not statistically sig)
Pulled from market due to lack of interest and cumbersome with restrictions
Inhaled Insulin (Afrezza)
rapid acting waiting approval No lingering insulin in lung smaller apparatus lower incidence of hypoglycaemia fewer restrictions no weight gain
Drugs the decrease the hypoglycaemic effect
AIDS antivirals, Albuterol, Oral contraceptives, corticosteroids, diltiazem, diuretics, epinephrine, estrogen, lithium, morphine sulfate, niacin, phenothiazines, thyroid hormones
Drugs that increase the hypoglycaemic effect
Alcohol, ACE inhibitors, antidiabetics, beta-blockers, calcium, clonidine, lithium, MAOIs, Salicyclates, Sulfonamides, Tetracycline
Oral Hypoglycemic Agents
Biguanide Thiazolidinediones Sulphonlureas Meglitinides Alpha-glucosidase inhibitors Incretin mimetics DPP inhibitors
Biguanide MoA
↓ Hepatic gluconeogenesis
↑ Peripheral insulin sensitivity
Slows intestinal abs. of sugars
Biguanide
metformin
Only oral hypoglycaemic proven to decrease CV mortality Does NOT cause hypoglycaemia Decreases HgA1C by 1.5-2% Modest benefit to lipid profile Taken with meals Modest weight loss (loss of appetite)
Biguanide Adverse Effects
LACTIC ACIDOSIS GI discomfort DIARRHEA metallic taste nausea anorexia
Biguanide Contraindications
Renal Disease
CHF, metabolic acidosis, patients over 80, lactation
Biguanide precautions
During surgery with use of contrast dyes
contrast dies can cause kidney failure increasing risk of lactic acidosis
Biguanide Interactions
Cimetidine, furosemide (compete for excretion)
Biguanide Drug Interactions
Interfere with abs of B12
Alcohol
Cimetidine, furosemide, nifedipine
Biguanide use
2-3x/day
no result after 4 weeks add sulfonylurea
extended-release formulation 1x/day with evening meal
Thiazolidinediones (TZD)
Enhance insulin sensitivity Glitazones pioglitazone rosiglitazone troglitazone (liver toxicity) Can be used in patients with renal insufficiency and the elderly
MOA thiazolidinediones?
Bind to PPAR-gamma receptor site without increasing insulin secretion from beta cells
Inc insulin sensitivity in liver, muscle, adipose tissue.
Thiazolidinediones PK
High serum albumin binding
Extensive P450 metabolism
Active metabolites excreted through urine
Parent drug excreted in bile
Thiazolidinedione advantages
May be taken irrespective of meals does not cause hypoglycaemic events Reduces TG, blood sugar, insulinemia, HbA1C Safe in renal failure Expansion of subcutaneous fat
Thiazolidinediones warning
Congestive Heart Failure
cause or exacerbate
Thiazolidinedione Adverse Effects
Weight gain Osteopenia Effects on Cholesterol Fluid retention Watch for hepatotoxicity
Thiazolidinediones Interactions
Oral contraceptives
Thiazolidinediones Contraindications
Severe heart failure
Thiazolidinediones Precautions
Edema, CVD, liver or kidney disease